Your Ad Here

Monday, May 25, 2009

Malvinder Singh Ranbaxy CEO Resigns

veer on Monday, May 25, 2009 |

Mr Malvinder Mohan Singh
Ranbaxy CMD

Ranbaxy CMD, Mr Malvinder Mohan Singh on Sunday stepped down, paving the way for appointment of Mr Atul Sobti as the new CEO and MD for three years.

Mr Tsutomu Une, non-executive director, has been elected as Chairman of the Board of Ranbaxy Laboratories.

“Mr Malvinder decided that he needs to leave Ranbaxy,” Mr Sobti said in a press conference where the reconstitution of the management team was announced. Mr Sobti at present is Ranbaxy's Chief Operating Officer.

Mr Une said Ranbaxy will remain a listed company. “We want to keep Ranbaxy as a listed company,” he said. The decision to appoint Mr Sobti and Mr Une was taken at the Board's meeting today.

Ranbaxy board has approved the decision to effect change in the management team. The change of guard comes nearly a year after Ranbaxy was acquired by Japanese drug major Daiichi-Sankyo.

Daiichi had acquired majority stake in Ranbaxy for about Rs 22,000 crore.

“It was a difficult decision to separate from Ranbaxy. But it was the right time for me to do so. I leave with complete confidence that initial transition phase followed Daiichi's acquisition of majority share holding interest in Ranbaxy has been complet ed successfully” Mr Malvinder Mohan Singh said in a Ranbaxy release.


source: Businessline

0 comments:

Post a Comment

Disclaimer

Information presented on this site is a guide only. It may not necessarily be correct and is not intended to be taken as financial advice nor has it been prepared with regard to the individual investment needs and objectives or financial situation of any particular person. The blogs/posts are an information service only. Recommendations, opinions or suggestions are given with the understanding that readers acting on this information assume all risks involved. We do not assume any responsibility or liability resulting from the use of such information, judgment and opinions for Trading or Investment purposes. Stock quotes are believed to be accurate and correctly dated, but Stockxnews does not warrant or guarantee their accuracy or date.
 
Design by SXN. Converted To Blogger Template By SXN .